top of page
Inclisiran - A game changer in ASCVD management
Atherosclerotic cardiovascular disease (ASCVD) is amongst the leading causes of death worldwide, accounting for an estimated 19 million...
Dr. Geetika Gupta
Sep 104 min read
Semaglutide – the first type 2 diabetes oral pill in its class
Diabetes is a global epidemic affecting around 463 million adults worldwide (1). India is considered the diabetes capital of the world....
Dr. Lokesh Naik
Sep 104 min read
Lecanemab, a new hope for patients with early Alzheimer’s disease
The ability to think clearly and make decisions plays a central role in the overall well-being and quality of life in elderly...
Ms. Silpa Rani Gajavalli
Sep 105 min read
FDA approves Roctavian gene therapy for severe Haemophilia A
Halfway through the year 2023, BioMarin bagged the approval for an “adeno-associated virus serotype 5 (AAV5)” gene therapy by the United...
Ms. Pragya Agarwal
Sep 104 min read
Dapagliflozin offers new hope for HFrEF patients
Heart failure (HF) is one of the most common cardiovascular diseases worldwide. The prevalence of heart failure in India is estimated to...
Ms. Leena Patil
Sep 103 min read
Ribociclib in the treatment of breast cancer
Breast cancer is the most common cancer affecting millions worldwide. Around 2.3 million women were diagnosed with breast cancer in 2020....
Dr. Vamsi Danyasi
Sep 105 min read
Management of osteoporosis with Teriparatide
Osteoporosis is a global health concern that affects millions worldwide. This condition leads to low bone mass and structural...
Ms. Shailly Dave
Sep 104 min read
Dupilumab: A Revolutionary Biologic Therapy for Atopic Dermatitis
Skin plays an important role for host defence system by providing tangible barrier, innate and acquired immunity. These three levels...
Ms. Shakini Kaul Bamzai
Sep 105 min read
Treatment regimen for Tuberculosis (TB) disease
Tuberculosis (TB) remains a significant public health concern worldwide. It is the second leading cause of death from infectious...
Ms. Paribha Gupta
Sep 104 min read
Effectiveness of Tofacitinib in the treatment of Rheumatoid Arthritis
There are several misconceptions around arthritis and rheumatoid arthritis. While arthritis refers to the inflammation of the joint...
Dr. Abhaya Prabhu
Sep 104 min read
Ayurvedic treatment of arthritis is safer
Lila was the most active member of our community. She had always been a lively and outgoing person, but one day she started experiencing...
Dr. Geetika Gupta
Sep 104 min read
The gut-brain axis - the bi-directional communication channel
The human gut contains a complex ecosystem of over 10 trillion microorganisms, including bacteria, fungi, yeasts, and protozoa, known as...
Ms. Disha Goyal
Sep 104 min read
U.S. FDA approves low dose Colchicine for ASCVD risk reduction
Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality worldwide, affecting over 500 million...
Dr. Uttara Shankar
Sep 104 min read
Dapagliflozin is approved for treating paediatric type 2 diabetes
Type 2 diabetes mellitus (T2D) is a progressive metabolic disease that affects members of all ages but is more common in people over 45...
Dr. Geetika Gupta
Sep 106 min read
Role of CARVYKTI® in the treatment of Multiple Myeloma
Multiple myeloma (MM) is one of the most common haematological cancers, with an incidence rate of 10%. As per the GLOBOCON 2022 update,...
Ms. Tanvi Goel
Sep 105 min read
Application of micrografting technology in managing AGA
Hair follicles are unique “mini-organs” that regenerate through a growth cycle of anagen (growth), catagen (involution), telogen...
Dr. Pooja Kumari
Sep 94 min read
Role of Levonadifloxacin against MDR infections
Antimicrobial resistance (AMR) has emerged as a major global health threat. The World Health Organization (WHO) has recognized AMR as a...
Dr. Ujwala Kemkar
Sep 95 min read
Bevacizumab treatment for patients with recurrent ovarian cancer
Ovarian cancer is highly prevalent and accounts for high mortality rate among cancers relating to female reproductive system (1). As per...
Dr. Sishir Kumar
Sep 95 min read
Pravastatin vs Atorvastatin: PROVE IT TIMI 22 Study
Cannon CP et al conducted a clinical study (PROVE IT TIMI 22) to assess the benefits of intensive statin therapy vs. moderate statin...
Mrs. Purnima Reddy
Sep 92 min read
Oral Semaglutide vs Empagliflozin: PIONEER 2 Study
Rodbard HW et al conducted the PIONEER 2 clinical study to assess the efficacy of oral Semaglutide in comparison with Empagliflozin in...
Ms. Tanvi Goel
Sep 91 min read
bottom of page